Literature DB >> 19104168

Rigid laryngoscope-assisted insertion of transesophageal echocardiography probe reduces oropharyngeal mucosal injury in anesthetized patients.

SungWon Na1, Chang Seok Kim, Ji Young Kim, Jin Seon Cho, Ki Jun Kim.   

Abstract

BACKGROUND: Intraoperative transesophageal echocardiography has become a routine part of monitoring in patients with cardiac disease. However, insertion of a transesophageal echocardiography probe can be associated with oropharyngeal, esophageal, and gastric injuries. The purpose of this study was to determine whether insertion of a transesophageal echocardiography probe under direct laryngoscopic visualization can reduce the incidence of oropharyngeal mucosal injury.
METHODS: Eighty patients undergoing surgery with general anesthesia were randomly allocated to either the conventional group, in which the probe was inserted blindly, or the laryngoscope group, in which a rigid laryngoscope was used to visualize the passage of the probe. The incidence of oropharyngeal mucosal injury, the number of insertion attempts, and odynophagia were assessed.
RESULTS: There was no significant difference in demographic and hemodynamic parameters between the 2 groups. The incidence of oropharyngeal mucosal injury was higher in the conventional group than in the laryngoscope group (55% vs. 5%, P < 0.05). The incidence of odynophagia was higher in the conventional group than in the laryngoscope group (32.5% vs. 2.5%, P < 0.05). The number of insertion attempts was also higher in the conventional group than in the laryngoscope group.
CONCLUSION: Rigid laryngoscope-assisted insertion of the transesophageal echocardiography probe reduces the incidence of oropharyngeal mucosal injury, odynophagia, and the number of insertion attempts.

Entities:  

Mesh:

Year:  2009        PMID: 19104168     DOI: 10.1097/ALN.0b013e318190b56e

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Hypopharyngeal perforation caused by intraoperative transesophageal echocardiography.

Authors:  Shigeru Toyoda; Shu Inami; Taito Masawa; Ikuko Shibasaki; Yasuyuki Yamada; Hirotsugu Fukuda; Tsukasa Kubo; Masanobu Nakajima; Hiroyuki Kato; Teruo Inoue
Journal:  J Med Ultrason (2001)       Date:  2014-11-26       Impact factor: 1.314

2.  [Intraoperative transesophageal echocardiography as monitoring procedure in noncardiac surgery patients].

Authors:  V Umrath; C Dumps; B Rupprecht; J Schimpf; J Benak
Journal:  Anaesthesist       Date:  2021-11-11       Impact factor: 1.041

3.  Transesophageal echocardiography (TEE)-induced Mallory-Weiss laceration in a patient who underwent aortic and mitral valve replacement -A case report-.

Authors:  Joo Yeon Lee; Dae Myoung Jeong; Sang Hyun Lee; Sangmin M Lee
Journal:  Korean J Anesthesiol       Date:  2010-12-31

4.  McGRATH MAC video laryngoscope assistance during transesophageal echocardiography may reduce the risk of complications: a manikin study.

Authors:  Taisuke Kumamoto; Koichiro Tashima; Chieko Hiraoka; Yoshihiro Ikuta; Tatsuo Yamamoto
Journal:  BMC Anesthesiol       Date:  2021-01-11       Impact factor: 2.217

5.  Complications related to intraoperative transesophageal echocardiography in liver transplantation.

Authors:  Sher-Lu Pai; Stephen Aniskevich; Neil G Feinglass; Beth L Ladlie; Claudia C Crawford; Prith Peiris; Klaus D Torp; Timothy S Shine
Journal:  Springerplus       Date:  2015-09-04

6.  Efficacy of Intravenous Lidocaine During Endoscopic Submucosal Dissection for Gastric Neoplasm: A Randomized, Double-Blind, Controlled Study.

Authors:  Ji Eun Kim; Jong Bum Choi; Bon-Nyeo Koo; Hae Won Jeong; Byung Ho Lee; So Yeon Kim
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  McGRATH MAC video laryngoscope for insertion of a transoesophageal echocardiography probe: A randomised controlled trial.

Authors:  Takashi Ishida; Chiaki Kiuchi; Takemi Sekiguchi; Takatoshi Tsujimoto; Mikito Kawamata
Journal:  Eur J Anaesthesiol       Date:  2016-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.